HeartFlow, Inc. is uniquely positioned at the intersection of artificial intelligence and healthcare to transform how heart disease is diagnosed and treated. Our HeartFlow Analysis is a non-invasive, personalized cardiac test for stable symptomatic patients with coronary artery disease (CAD), the #1 cause of death worldwide.
Starting with a standard coronary CT scan, the HeartFlow Analysis leverages deep learning and highly trained analysts to create a digital 3D model of the patient’s coronary arteries. Millions of complex algorithms are then applied to simulate blood flow and assess the impact of blockages on blood flow to the heart. The interactive, color coded 3D model is provided via a secure online interface and enables physicians to determine the optimal course of treatment for their patients.
The HeartFlow Analysis is covered by Medicare and most private commercial payors. To date, more than 30,000 patients worldwide have received a HeartFlow Analysis.
Learn more about the genesis of HeartFlow from our co-founders and about the impact the HeartFlow Analysis is having on their practices from physicians around the world.
Prairie Heart Institute
It took a coalition of cardiologists, radiologists, administrators and others at Prairie Heart Institute at HSHS St John’s Hospital to evaluate, implement and measure the impact of using the HeartFlow Analysis. The results have been positive for the patients, physicians and hospital. Hear why they adopted the HeartFlow Analysis and what has made their implementation so successful.